The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis

The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis

BackgroundHepatitis C virus (HCV) infection is an independent risk factor associated with adverse outcomes in patients with end-stage renal disease (ESRD). Due to the wide variety of direct-acting antiviral regimens (DAAs) and the factor of renal insufficiency, careless selection of anti-hepatitis C...

Full description

Bibliographic Details
Main Authors: Ruochan Chen, Yinghui Xiong, Yanyang Zeng, Xiaolei Wang, Yinzong Xiao, Yixiang Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Public Health
Subjects:
hepatitis (C) virus
end-stage renal disease
direct-acting antiviral
Bayesian Markov Chain Monte Carlo
network meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1179531/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2023.1179531/full

Similar Items